DBV Technologies DBVT
NASDAQ DBVT
$13.47 -0.23 (-1.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

DBV Technologies (DBVT) Goodwill & Intangibles (2015 - 2026)

DBV Technologies (DBVT) posted Goodwill & Intangibles of $100000.0 for Q1 2026, up 376.19% sequentially from $21000.0 in Q3 2025, and up 244.83% YoY from $29000.0 in Q1 2025.

Analysis

DBV Technologies (DBVT) Goodwill & Intangibles (2015 - 2026) Analysis & Trends

DBV Technologies has reported Goodwill & Intangibles for 12 years, with the latest figure at $100000.0 in Q1 2026.

  • Quarterly Goodwill & Intangibles rose 244.83% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100000.0 (up 244.83% YoY) and the FY2024 annual result came in at $40000.0, down 31.03% from the prior year.
  • Goodwill & Intangibles rose to $100000.0 in Q1 2026 per DBVT's latest filing, from $21000.0 in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $100000.0 in Q1 2026 and troughed at $10000.0 in Q4 2022.
  • A 5-year average of $37937.5 and a median of $34500.0 in 2024 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles sank 57.69% in 2022, then soared 480.0% in 2023.
  • Over 5 years, Goodwill & Intangibles stood at $10000.0 in 2022, then jumped by 480.0% to $58000.0 in 2023, then sank by 31.03% to $40000.0 in 2024, then tumbled by 47.5% to $21000.0 in 2025, then soared by 376.19% to $100000.0 in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $100000.0, $21000.0, and $26000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 DBV Technologies 5.88 Bn 5.70 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Sep 30, 2025 21,000.00
Jun 30, 2025 26,000.00
Mar 31, 2025 29,000.00
Dec 31, 2024 40,000.00
Sep 30, 2024 43,000.00
Jun 30, 2024 46,000.00
Mar 31, 2024 52,000.00
Dec 31, 2023 58,000.00
Sep 30, 2023 61,000.00
Jun 30, 2023 68,000.00
Mar 31, 2023 10,000.00
Dec 31, 2022 10,000.00
Sep 30, 2022 11,000.00
Jun 30, 2022 14,000.00
Mar 31, 2022 18,000.00
Dec 31, 2021 22,000.00
Sep 30, 2021 26,000.00
Jun 30, 2021 25,000.00
Mar 31, 2021 32,000.00